Akso Health Group
7 hedge funds and large institutions have $448K invested in Akso Health Group in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
75% more funds holding
Funds holding: 4 → 7 (+3)
0.12% less ownership
Funds ownership: 0.84% → 0.72% (-0.12%)
24% less capital invested
Capital invested by funds: $590K → $448K (-$142K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$24.6K |
| 2 |
Millennium Management
New York
|
+$15.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$129K |
| 2 |
Two Sigma Investments
New York
|
-$8.81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $303K | -$129K | -121,150 | -27% |
|
|
2
Two Sigma Investments
New York
| $101K | -$8.81K | -8,300 | -7% |
|
|
3
Citadel Advisors
Miami,
Florida
| $21K | +$24.6K | +23,209 | New |
|
|
4
Millennium Management
New York
| $14K | +$15.9K | +14,959 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | +$7.11K | +6,697 | New |
|
6
Morgan Stanley
New York
| $3K | – | – | – |
|
AHG Hedge Fund Activity: Q3 2022 in Review
7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q3 2022, worth a combined $448K — down 24% from $590K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AHG positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $24.6K. The largest seller was Renaissance Technologies, cutting an estimated $129K.
- 7 institutional investors held Akso Health Group (AHG) as of Q3 2022, up from 4 in Q2 2022.
- Funds reported $448K of Akso Health Group stock for Q3 2022, down 24% quarter-over-quarter.
- 3 funds opened new Akso Health Group positions in Q3 2022 and 0 closed out, a net change of +3 holders.
- The largest Akso Health Group buyer in Q3 2022 was Citadel Advisors, an estimated $24.6K added.
- The largest Akso Health Group seller in Q3 2022 was Renaissance Technologies, an estimated $129K sold.
Based on aggregated 13F filings for Q3 2022.